Host defence peptide plectasin targets bacterial cell wall precursor lipid II by a calcium-sensitive supramolecular mechanism.
Shehrazade JekhmaneMaik G N DerksSourav MaityCornelis J SlingerlandKamaleddin H M E TehraniJoao Medeiros-SilvaVicky CharitouDanique AmmerlaanCéline FetzNaomi A ConsoliRachel V K CochraneEilidh J MathesonMick van der WeijdeBarend O W ElenbaasFrancesca LavoreRuud CoxJoseph Helmuth LorentMarc BaldusMarkus KünzlerMoreno LelliStephen A CochraneNathaniel I MartinWouter H RoosEefjan BreukinkMarkus H WeingarthPublished in: Nature microbiology (2024)
Antimicrobial resistance is a leading cause of mortality, calling for the development of new antibiotics. The fungal antibiotic plectasin is a eukaryotic host defence peptide that blocks bacterial cell wall synthesis. Here, using a combination of solid-state nuclear magnetic resonance, atomic force microscopy and activity assays, we show that plectasin uses a calcium-sensitive supramolecular killing mechanism. Efficient and selective binding of the target lipid II, a cell wall precursor with an irreplaceable pyrophosphate, is achieved by the oligomerization of plectasin into dense supra-structures that only form on bacterial membranes that comprise lipid II. Oligomerization and target binding of plectasin are interdependent and are enhanced by the coordination of calcium ions to plectasin's prominent anionic patch, causing allosteric changes that markedly improve the activity of the antibiotic. Structural knowledge of how host defence peptides impair cell wall synthesis will likely enable the development of superior drug candidates.
Keyphrases
- cell wall
- antimicrobial resistance
- magnetic resonance
- atomic force microscopy
- solid state
- fatty acid
- healthcare
- high speed
- water soluble
- high resolution
- magnetic resonance imaging
- emergency department
- type diabetes
- dna binding
- risk factors
- high throughput
- cardiovascular events
- computed tomography
- cardiovascular disease
- coronary artery disease
- mass spectrometry
- adverse drug